Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia

Pediatric Transplantation

Volumn 12, Issue 1, 2008, Pages 14-19

  George, Biju ^a   Mathews, Vikram ^a   Viswabandya, Auro ^a   Kavitha, M L ^a   Srivastava, Alok ^a   Chandy, Mammen ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Aplastic anemia; Fludarabine; Hematopoietic stem cell transplantation; Reduced intensity conditioning

Indexed keywords

AMPHOTERICIN B; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; FLUDARABINE; FOLINIC ACID; LYMPHOCYTE ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; OKT 3; PREDNISOLONE; STEROID; THALIDOMIDE; THYMOCYTE ANTIBODY; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HLA SYSTEM; HUMAN; MALE; MYCOSIS; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; THROMBOCYTE; TREATMENT INDICATION;

ADOLESCENT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MYELOABLATIVE AGONISTS; TRANSPLANTATION CONDITIONING; VIDARABINE;

EID: 37849024608     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00825.x     Document Type: Article

References (23)

1. Locasciulli A. Acquired aplastic anemia in children: Incidence, prognosis and treatment options. Paediatr Drugs 2002 : 4 : 761 766.
2. Van Steekelenburg M, Van Weel-Sipman MH, Zwinderman AH, et al. Favorable current prognosis after HLA-identical bone marrow transplantation for children with severe aplastic anemia: Evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center. Ned Tijdschr Geneeskd 2002 : 146 : 1542 1546.
3. Kojima S, Horibe K, Inaba J, et al. Long term outcome of acquired aplastic anemia in children: Comparison between immunosuppressive therapy and bone marrow transplantation. Br J Haematol 2000 : 111 : 321 328.
4. Munoz Villa A, Ortega Aramburu JJ, Bureo Dacal E, et al. Allogeneic bone marrow transplantation in children with severe acquired aplastic anemia. The long-term results. The Spanish Group for Bone Marrow Transplantation in Children (GETMON). An Esp Pediatr 1999 : 50 : 29 32.
5. Gillio AP, Boulad F, Small TN, et al. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation. Biol Blood Marrow Transplant 1997 : 3 : 18 24.
6. Gluckman E, Horowitz MM, Champlin RE, et al. Bone marrow transplantation for severe aplastic anemia: Influence of conditioning and graft-versus host disease prophylaxis regimens on outcome. Blood 1992 : 79 : 269 275.
7. Deeg HJ, Self S, Storb R, et al. Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: Changing impact of risk factors. Blood 1986 : 68 : 1363 1368.
8. Storb R, Prentice RL, Thomas ED. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 1977 : 296 : 61 66.
9. Champlin RE, Horowitz MM, Van Bekkum DW, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 1989 : 73 : 606 613.
10. Kobayashi R, Yabe H, Hara J, et al., Japan Childhood Aplastic Anemia Study Group Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings. Br J Haematol 2006 : 135 : 693 696.
11. Chandy M, Srivastava A, Dennison D, et al. Allogeneic bone marrow transplantation in the developing world: Experience from a center in India. Bone Marrow Transplant 2001 : 27 : 785 790.
12. Zapatero A, Marin A, Lopez M, et al. Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: Long-term follow-up. Hematol Oncol 1996 : 14 : 165 172.
13. Urban C, Benesch M, Sykora KW, et al. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia. Bone Marrow Transplant 2005 : 35 : 591 594.
14. Bacigalupo A, Locatelli F, Lanino E, et al., Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Fludarabine, Cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired aplastic anemia: A report from the EBMT-SAA working party. Bone Marrow Transplant 2005 : 36 : 947 950.
15. Vassiliou GS, Webb DK, Pamphilon D, et al. Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath. Br J Haematol 2001 : 114 : 701 705.
16. Resnick IB, Aker M, Shapira MY, et al. Allogeneic stem cell transplantation for severe acquired aplastic anemia using a fludarabine based preparative regimen. Br J Haematol 2006 : 133 : 649 654.
17. Koh LP, Koh MB, Ng HY, et al. Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200 cG total body irradiation and fludarabine. Biol Blood Marrow Transplant 2006 : 12 : 887 890.
18. Gomez-Almaguer D, Vela-Ojeda J, Jaime-Perez JC, et al. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: The Mexican experience. Am J Hematol 2006 : 81 : 157 161.
19. Gupta V, Ball SE, Sage D, et al. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant 2005 : 35 : 467 471.
20. Srinivasan R, Takahashi Y, Mccoy JP, et al. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol 2006 : 133 : 305 314.
21. Gomez-Almaguer D. The simplification of the SCT procedures in developing countries has resulted in cost-lowering and availability to more patients. Int J Hematol 2002 : 76 (Suppl. 1 380 382.
22. Schrezenmeier H, Passweg JR, Marsh JC, et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia: A report from the European Group for Blood and Marrow Transplantation and the Center for International Blood and Marrow Transplant Research. Blood 2007 In press)
23. Herrera-Garza J, Jaime-Perez J, Montemayor J, et al. High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anemia patients without antithymocyte globulin in the conditioning regimen. Bone Marrow Transplant 1999 : 24 : 845 848.